| Ferring AG - Lutrelef 3,2 mg, Injektionspräparat |
| 47366 | | 02 | | Lutrelef 3,2 mg | | Injektionspräparat | | H01CA01 | | Gonadorelin | | 04.08.1986 | | |
|
| Composition |
| Praeparatio cryodesiccata: gonadorelini acetas 3.2 mg corresp. gonadorelinum 2.91 mg, mannitolum acidum hydrochloridum, pro vitro.
Solvens: natrii chloridum corresp. natrium 35.4 mg, acidum hydrochloridum, aqua ad iniectabile 10 ml. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | Injection preparation | | | | | | | | Active Agent | Dose |
|---|
| Gonadorelini Acetas | 3.2 mg correspond Gonadoreline 2.91 mg |
| | BAG: Active Agent | Dose |
|---|
| Gonadorelini Diacetas | 3.2 mg |
| | | | Inactive agents |
|---|
| Mannitolum Acidum Hydrochloridum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 038 | Durchstechflasche(n) | 300.71 | 343.45 | B | SL | No |
|
